Catalyst Wire Dossier Catalyst Wire Dossier

ANKASCIN 568-P

· SunWay Biotech Co., LTD.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ANKASCIN 568-P, covering 2025-08-28 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Effect of ANKASCIN 568-P Products Regulating Blood Lipid [NA]

See pricing